Entering text into the input field will update the search result below

NovaBay Pharmaceuticals, Inc. (NBY)

Dec. 08, 2020 3:13 PM ET
traderspro profile picture
traderspro's Blog
50 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Summary

  • Stocks found in the category TradersPro New Uptrend are low priced stocks priced between .50 and $3, with at least 50k shares of average shares trading per day.
  • Trailing stops or letting the stock run until the next sell signal is also a sell strategy.
  • These are high reward to risk stocks with the potential for very sharp moves.

Stocks That Can Move 400-1500% or More!

You too can buy the best stocks at the best time in under 30 mins a day. Stop wasting time looking for the right stocks. Free training on how to find perfect stock trades that can move 400-1,500%. Get a list of top high flighers with new buy signals now.

Click Here Now

Trade Setup

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products to address therapeutic needs of the anti-infective market in the United States and internationally.


Stock Picking Secrets - Now you can buy the best stocks at the best time in under 30 mins a day. See How


Stocks found in the category TradersPro New Uptrend are low priced stocks priced between .50 and $3, with at least 50k shares of average shares trading per day. The stocks are starting new uptrends and have buy signals. These are high reward to risk stocks with the potential for very sharp moves. A stop should be maintained at the low of the most recent hold signal day. Target prices for exits can be determined by using the next level of resistance higher or by using Fibonacci resistance levels found using TradersPro. Trailing stops or letting the stock run until the next sell signal is also a sell strategy.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You